These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7492770)

  • 1. Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein.
    Ravon DM; Citarella F; Lubbers YT; Pascucci B; Hack CE
    Blood; 1995 Dec; 86(11):4134-43. PubMed ID: 7492770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
    Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Meijers JC; Bouma BN; Hack CE
    J Biol Chem; 1989 Aug; 264(22):12941-9. PubMed ID: 2473984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.
    Citarella F; Wuillemin WA; Lubbers YT; Hack CE
    Br J Haematol; 1997 Oct; 99(1):197-205. PubMed ID: 9359524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
    Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
    Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg 353-->Pro leading to loss of a kallikrein cleavage site.
    Hovinga JK; Schaller J; Stricker H; Wuillemin WA; Furlan M; Lämmle B
    Blood; 1994 Aug; 84(4):1173-81. PubMed ID: 8049433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on factor XII in porcine plasma: purification and its conversion to activated form by porcine plasma kallikrein.
    Mashiko H; Kato K; Fujii K; Takahashi H
    Biochim Biophys Acta; 1996 Sep; 1296(2):198-206. PubMed ID: 8814227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
    Tans G; Rosing J; Griffin JH
    J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The function of the heavy and light chain of human plasma kallikrein in the activation of factor XII.
    Rosing J; Tans G; Griffin JH
    Adv Exp Med Biol; 1986; 198 Pt B():27-34. PubMed ID: 3492870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation.
    Pixley RA; Stumpo LG; Birkmeyer K; Silver L; Colman RW
    J Biol Chem; 1987 Jul; 262(21):10140-5. PubMed ID: 2440859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain.
    Rosing J; Tans G; Griffin JH
    Eur J Biochem; 1985 Sep; 151(3):531-8. PubMed ID: 3875484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of bradykinin: a major contributor to the innate inflammatory response.
    Joseph K; Kaplan AP
    Adv Immunol; 2005; 86():159-208. PubMed ID: 15705422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.